文献速递生殖医学

固定低剂量FSH刺激在IUI方案中卵巢反应的影响因素:PRORAILS研究

Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study.
PubMed 文献 · Hum Reprod · 2022-01-01

PRORAILS是一项在荷兰15家医院开展的前瞻性多中心队列研究,纳入492例不明原因或轻度男性不育接受IUI联合卵巢过度刺激的患者,评估AMH、BMI等对卵巢反应(以>15mm主导卵泡数定义)的预测价值。结果显示血清AMH与卵巢反应无稳固关系,多数患者(66%)为次优反应,BMI和基础FSH是低反应和高反应的显著预测因素,加用AMH未改善预测能力;研究未针对妊娠和活产进行效能计算。

要点

  • 492例患者中66%为次优卵巢反应,其中45%为低反应(<2个>15mm卵泡),21%为高反应(>3个>15mm卵泡)。
  • 血清AMH与卵巢反应无稳固关系,最低AMH类别与次优反应风险降低的趋势未达统计学显著(相对风险比0.76,95%CI 0.54-1.06)。
  • BMI和基础FSH是低反应的显著预测因素,年龄、BMI和FSH是高反应的显著预测因素,加用AMH未改善预测能力。

核心结论

  • 血清AMH与IUI卵巢过度刺激中的卵巢反应无稳固关系,多数患者出现次优反应,BMI和FSH对低反应和高反应有显著预测作用。

研究设计与样本

  • 前瞻性多中心全国性队列研究,纳入492例接受首个IUI刺激周期的不明原因或轻度男性不育患者,2012年至2017年在荷兰15家医院开展,随访至妊娠则至分娩。

主要发现

  • 492例患者平均年龄33岁,平均不育时长2.5年,血清AMH中位数2.1 µg/l。
  • 326例(66%)为次优反应,其中224例(45%)为低反应(<2个>15mm卵泡),102例(21%)为高反应(>3个>15mm卵泡)。
  • 最低AMH类别与次优反应风险降低的趋势相对风险比为0.76(95%CI 0.54-1.06),未达统计学显著。
  • 预测模型中BMI和血清基础FSH是低反应的显著预测因素,年龄、BMI和血清FSH是高反应的显著预测因素。
  • 较高的BMI和较高的FSH与低反应风险升高相关,较低的BMI和较低的FSH与高反应风险升高相关;加用AMH未改善预测能力。

临床怎么用

  • 作者认为未来研究可从随机设计探讨个体化方案与固定剂量的有效性,并可进一步研究良好卵巢刺激与妊娠率的关系。

局限性

  • 研究虽为前瞻性,但主要分析为横断面,特征仅在一个时间点测量。
  • 研究未针对妊娠和活产的预测因素进行效能计算,因此妊娠结果应谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are patients' characteristics, such as anti-Müllerian hormone (AMH) and BMI, reliable factors to predict ovarian response in couples with unexplained subfertility undergoing IUI with ovarian hyperstimulation (IUI-OH)? SUMMARY ANSWER: We observed no solid relationship between serum AMH and ovarian response. WHAT IS KNOWN ALREADY: Ovarian stimulation during IUI treatment could lead to a higher chance of pregnancy, but also a higher incidence of multiple pregnancies, unless strict cancellation criteria are being used. Several factors could influence the result of the stimulation, such as age, BMI and hormonal status of the female. In IVF treatment, AMH has shown to be a useful predictor of ovarian stimulation to optimize the outcome; however, in a milder stimulation protocol, such as IUI, this has not been investigated. STUDY DESIGN, SIZE, DURATION: We performed a prospective cohort study and evaluated the first IUI stimulation cycle of 492 patients. The study was conducted between 2012 and 2017. Follow-up ended if patients were not pregnant after the first cycle. If pregnancy did occur, follow-up lasted until delivery. PARTICIPANTS/MATERIALS, SETTING, METHODS: PRORAILS is a large multicentre nationwide cohort study executed in the Netherlands. Eligible women aged 18-43 years who were diagnosed with unexplained subfertility or mild male subfertility according to the Dutch guideline, with a regular indication for IUI-OH, were asked to participate. Ovarian response was assessed using a transvaginal ultrasound 5-7 days after initiation of the stimulation and was repeated according to the size of the leading follicles. Ovarian response was defined as optimal or suboptimal based on the total number of dominant follicles >15 mm. A successful stimulation was defined as the presence of two to three follicles >15 mm on the day of hCG administration. Serum AMH (µg/l) was measured by ELISA, and samples were taken on day 2, 3 or 4 of the menstrual cycle. Poisson regression was used to estimate the risk of a suboptimal ovarian response. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 492 participants, the mean age was 33 years and the mean subfertility duration was 2.5 years. The median serum AMH was 2.1 (µg/l). The majority of patients had a suboptimal response: 326 women (66%), of whom 224 (45%) had a hypo response (defined as <two follicles sized > 15 mm) and 102 (21%) had a hyper response (defined as more than three follicles sized >15 mm). The lowest AMH category showed a trend towards a smaller risk of a suboptimal response (relative risk ratio 0.76 (95% CI 0.54, 1.06)), but this effect did not reach statistical significance. In the prediction models, BMI and serum basal FSH were significant predictors of a hypo response, while for hyper response the factors age, BMI and serum FSH were significant. A higher BMI showed a higher risk for hypo response, as did a higher FSH whereas a lower BMI and lower FSH showed a higher risk for hyper response. The addition of AMH to the models did not improve the predictive abilities. LIMITATIONS, REASONS FOR CAUTION: Although the study was prospective, the main analyses were cross-sectional with characteristics measured at one time-point. The study was not powered to provide insight into predictors of pregnancy and live births and, therefore, the result for pregnancy should be interpreted with caution. WIDER IMPLICATIONS OF THE FINDINGS: This was the first large multicentre study that investigated the characteristics of ovarian response categories using standardized methods and centrally analysed laboratory measures. PRORAILS is a nationwide study with 15 hospitals and, therefore, these results are generalizable to other hospitals in the Netherlands. This study provides high-quality outcomes advancing the subfertility research field. Future studies would benefit from a randomized design investigating the effectiveness of an individualized approach versus a fixed dose. Also, the relation between a good ovarian stimulation and pregnancy rate could be further investigated. STUDY FUNDING/COMPETING INTEREST(S): The PRORAILS study is sponsored by Merck B.V., Schiphol-Rijk, the Netherlands, an affiliation of Merck KGaA, Darmstadt, Germany (EMR700623_612). Merck KGaA, Darmstadt, Germany, reviewed the manuscript prior to submission. The opinions remain those of the authors. Merck KGaA, Darmstadt, Germany, had no influence on the use of medication in this study. The recombinant FSH was mostly provided by Merck B.V. or MSD. F.B. is a member of the external advisory board for Merck B.V., Schiphol-Rijk, the Netherlands, and has received a research grant from Merck B.V., Schiphol-Rijk. H.v.B. is an employee from IQVIA, which is a commercial data-analysing company, and received payment for her part in the article. TRIAL REGISTRATION NUMBER: NCT01662180.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Rutten A, van Ballegooijen H, Broekmans F, et al. Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study. Hum Reprod. 2022. PMID: 35460412. doi:10.1093/humrep/deac076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。